Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ogbe A. et al, (2022), JCI Insight, 7

SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.

Shankar S. et al, (2022), Journal of the American Society of Nephrology : JASN

Ribavarin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Salam AP. et al, (2022), PLoS Negl Trop Dis, 16

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Tomic A. et al, (2022), Nature communications, 13

Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.

Gray-Rodriguez S. et al, (2022), The Journal of pathology

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Mellors J. et al, (2022), Frontiers in immunology, 13

Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.

Gartlan C. et al, (2022), Frontiers in immunology, 13

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

Lambe T. et al, (2021), Communications Biology, 4

Quantification of type i interferon inhibition by viral proteins: Ebola virus as a case study

Locke M. et al, (2021), Viruses, 13

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine

Marriott AC. et al, (2021), npj Vaccines, 6

Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye.

Watson RJ. et al, (2021), Journal of virology, 95

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Payne RP. et al, (2021), Cell

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.

Huo J. et al, (2021), Nature communications, 12

Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection

Charman M. et al, (2021), Frontiers in Cellular and Infection Microbiology, 11

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application.

Hargreaves A. et al, (2021), Pathogens (Basel, Switzerland), 10

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks.

Keita AK. et al, (2021), Nature, 597, 539 - 543

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques.

Bewley KR. et al, (2021), Science advances, 7

Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS.

Aljabr W. et al, (2021), mSphere, 6

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13

Metagenomic identification of a new sarbecovirus from horseshoe bats in Europe.

Crook JM. et al, (2021), Sci Rep, 11

Load More

Include forthcoming?